QIAGEN N.V. (QGEN)
NYSE
$44.18−$0.3800 (−0.85%) on the dayAs of the close; data may be delayed.
QGEN price, last 12 months
Key stats
- Previous close
- $44.56
- Open
- $44.92
- Day range
- $44.00 – $44.92
- 52-week range
- $32.53 – $57.82
- Volume
- 1.2M
- Avg volume (20 days)
- 1.7M
- Market cap
- $9.1B
Performance
1W+2.0%
1M+1.9%
3M+12.1%
6M+11.3%
YTD−1.8%
1Y−2.0%
vs S&P 500, 1Y−18.8 pts
Technicals and fundamentals
About QIAGEN N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).
- Listed on
- NYSE
- Market cap
- $9.1B